We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Abaxis Signs Exclusive Distribution Agreement with Abbott

By LabMedica International staff writers
Posted on 05 Nov 2012
Abaxis, Inc. More...
(Union City, CA, USA) signed an exclusive multiyear distribution agreement with Abbott's Point-of-Care (POC; Princeton, NJ, USA) business to market and distribute the Piccolo Xpress, a portable clinical chemistry system, and its full line of one-time user reagent discs, to the human medical market.

Abbott will have the exclusive right to distribute and sell Abaxis' Piccolo Xpress chemistry analyzer and associated consumables in the US and China (including Hong Kong). Abaxis will retain the distribution rights to current customer Catapult Health (Dallas, TX, USA) and certain segments including pharmacy and retail store clinics, shopping malls, contract research organizations (CROs), and cruise ship lines. The company will provide technical support and warranty services to support Abbott's commercial efforts.

The Piccolo Xpress provides on-the-spot chemistry results in minutes. About the size of a shoebox, health care providers use the Piccolo Xpress's easy-to-follow color touch-screen commands to perform routine multi-chemistry panels. 0.1 mL of whole blood, serum, or plasma is added directly to the single use plastic disc containing the liquid diluent and dry reagents. The disc is placed in the analyzer drawer where centrifugal and capillary forces are used to mix the reagents and sample in the disc. The Piccolo Xpress monitors the reagent reactions simultaneously using nine wavelengths, calculates the results from the absorbance data, and reports the results. The easy-to-use, low maintenance system requires no special training to operate.

Abaxis develops, manufactures, markets, and sells portable blood analysis systems for use in any human patient-care or veterinary setting to provide clinicians with rapid blood constituent measurements.

Related Links:
Abaxis
Abbott's Point-of-Care


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.